Preclinical studies with trimetrexate: a review of conclusions and unanswered questions.
Jackson
R C
RC
Chemotherapy Department, Warner-Lambert Company, Ann Arbor, MI 48106.
Leopold
W R
WR
Hamelehle
K L
KL
Fry
D W
DW
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical; D004351:Drug Resistance; D006801:Humans; D011799:Quinazolines / Q000494:pharmacology* / Q000627:therapeutic use; D016597:Trimetrexate
D000970:Antineoplastic Agents; D011799:Quinazolines; D016597:Trimetrexate